Composition: Each tablet contains Hydralazine Hydrochloride BP 25 mg.
Usage: Treatment of high blood pressure under medical supervision.
Category: Antihypertensive / Vasodilator (corrected from Diuretic Drugs)
Therapeutic Category: Antihypertensive
SKU: Hydralazine Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Hydralazine Hydrochloride Tablets BP is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
Healthy Life Pharma Pvt. Ltd. manufactures Hydralazine Hydrochloride Tablets for the management of hypertension. Hydralazine is a direct-acting arteriolar vasodilator, not a diuretic. It reduces peripheral vascular resistance and blood pressure. In selected patients with heart failure, hydralazine is used together with isosorbide dinitrate under specialist supervision.
Contract manufacturing and export enquiries can be directed to Healthy Life Pharma Pvt. Ltd. and Healthy Inc. Specific production methods and export approvals should be confirmed for the product and destination market.
| Parameter | Specification |
|---|---|
| Product name | Hydralazine Hydrochloride Tablets BP |
| Confirmed strength | 25 mg per tablet |
| Composition | Hydralazine Hydrochloride BP 25 mg |
| Dosage form | Oral tablet; coating not specified |
| Pharmacopoeial reference | BP (as supplied) |
| Therapeutic class | Antihypertensive / direct arteriolar vasodilator |
| CAS (hydralazine hydrochloride) | 304-20-1 |
| Shelf life / packaging | Confirm from approved label and stability dossier |
Strength verification: 50 mg appears in the draft description but no 50 mg tablet composition was supplied, so it is not presented as a confirmed SKU.
Tablet manufacture requires appropriate raw-material identification, blending and content-uniformity controls, validated compression, and protection from conditions that may affect stability. Any use of special coatings, chelating agents, equipment configurations or dedicated packaging must be confirmed from the actual master formula and stability data; such processes are not assumed for this 25 mg tablet.
Typical quality controls include identity, assay, related substances, uniformity of dosage units, dissolution or disintegration as specified, and stability testing. Acceptance limits must follow the applicable BP monograph and approved finished-product specification. Product-specific certificates of analysis may be requested.
Hydralazine primarily relaxes arteriolar smooth muscle, lowering systemic vascular resistance. It is used for hypertension when clinically appropriate, often alongside other medicines to address reflex tachycardia and fluid retention. Hydralazine with isosorbide dinitrate has a separate evidence base and indication in selected patients with heart failure; the two treatments should not be treated as interchangeable.
Pregnancy: Hydralazine may be used by clinicians for certain severe hypertensive conditions in pregnancy, but oral 25 mg tablets are not a substitute for urgent evaluation and monitored emergency treatment.
Documentation such as certificate of analysis, manufacturing certificates, free-sale documentation and CTD/ACTD dossiers may be available subject to the registered product, destination-market rules and document verification. Packaging configurations and commercial shipping terms should be confirmed at enquiry.
Q: Who manufactures these tablets?
A: Healthy Life Pharma Pvt. Ltd., India.
Q: Is hydralazine a diuretic?
A: No. It is an antihypertensive vasodilator. Diuretics increase salt and water excretion through the kidneys.
Q: Can hydralazine cause a lupus-like reaction?
A: Yes. Risk is related to factors including dose, treatment duration and individual susceptibility. Seek medical review for new joint pain, fever or rash.
Q: Is 50 mg available?
A: The supplied composition confirms only the 25 mg BP tablet; other strengths require verification.
Take only as directed by the prescribing clinician. The dose and frequency depend on the indication, blood-pressure response, other medicines and tolerance. Do not use a fixed schedule from a website in place of the approved label. Follow the prescriber’s directions regarding meals and do not stop therapy abruptly without medical advice.
Store according to the approved product label in the original packaging, protected from excess heat, moisture and light as specified. Keep out of reach of children.